Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severe tumefactive rebound of multiple sclerosis following fingolimod cessation.

× No keyword cloud information.

3 in total

1. Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.

Authors: Joachim B Havla; Hannah L Pellkofer; Ingrid Meinl; Lisa Ann Gerdes; Reinhard Hohlfeld; Tania Kümpfel
Journal: Arch Neurol Date: 2012-02

Review 2. Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment.

Authors: Simon Faissner; Robert Hoepner; Carsten Lukas; Andrew Chan; Ralf Gold; Gisa Ellrichmann
Journal: Ther Adv Neurol Disord Date: 2015-09 Impact factor: 6.570

3. Dramatic recovery of steroid-refractory relapsed multiple sclerosis following Fingolimod discontinuation using selective immune adsorption.

Authors: Roberto De Masi; Salvatore Accoto; Stefania Orlando; Vincenzo De Blasi; Sergio Pasca; Rocco Scarpello; Leo Spagnolo; Adele Idolo; Antonella De Donno
Journal: BMC Neurol Date: 2015-07-31 Impact factor: 2.474

3 in total

Review 1. Neurological safety of fingolimod: An updated review.

Authors: Fumihito Yoshii; Yusuke Moriya; Tomohide Ohnuki; Masafuchi Ryo; Wakoh Takahashi
Journal: Clin Exp Neuroimmunol Date: 2017-06-18

2. Disease Exacerbation after the Cessation of Fingolimod Treatment in Japanese Patients with Multiple Sclerosis.

Authors: Kazunori Sato; Masaaki Niino; Atsushi Kawashima; Moemi Yamada; Yusei Miyazaki; Toshiyuki Fukazawa
Journal: Intern Med Date: 2018-04-27 Impact factor: 1.271

3. Severe rebound after cessation of fingolimod treated with ocrelizumab with coincidental transient aggravation: report of two cases.

Authors: Stephan Schmidt; Thomas Schulten
Journal: Ther Adv Neurol Disord Date: 2019-05-06 Impact factor: 6.570

3 in total